- Home
- NEO vs MFA Comparison
NEO vs MFA Comparison
Compare NEO & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NEO | MFA |
|---|---|---|
| Founded | 2001 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 976.0M |
| IPO Year | 1999 | N/A |
Fundamental Metrics
Financial Performance| Metric | NEO | MFA |
|---|---|---|
| Price | $12.46 | $9.72 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $11.38 | $10.96 |
| AVG Volume (30 Days) | ★ 1.7M | 1.1M |
| Earning Date | 10-28-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 14.68% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 0.86 |
| Revenue | ★ $709,162,000.00 | $279,011,000.00 |
| Revenue This Year | $10.90 | N/A |
| Revenue Next Year | $9.88 | $14.85 |
| P/E Ratio | ★ N/A | $11.41 |
| Revenue Growth | ★ 10.10 | N/A |
| 52 Week Low | $4.72 | $7.85 |
| 52 Week High | $19.12 | $11.08 |
Technical Indicators
Market Signals| Indicator | NEO | MFA |
|---|---|---|
| Relative Strength Index (RSI) | 67.58 | 57.75 |
| Support Level | $11.46 | $9.48 |
| Resistance Level | $12.19 | $9.88 |
| Average True Range (ATR) | 0.40 | 0.14 |
| MACD | -0.03 | 0.01 |
| Stochastic Oscillator | 85.90 | 59.30 |
Price Performance
Historical ComparisonAbout NEO NeoGenomics Inc.
NeoGenomics Inc provides oncology diagnostic testing and consultative services which include technical laboratory services and professional interpretation of laboratory test results by licensed physicians or molecular experts in pathology and oncology. It operates a network of cancer-focused testing laboratories in the United States and the United Kingdom. The company operates in a single segment and derives revenue from clients by providing clinical cancer testing, interpretation, and consultative services, molecular and NGS testing, comprehensive technical and professional services offerings, clinical trials and research, validation laboratory services, and oncology data solutions.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company's reportable segments include mortgage-related assets and Lima One.